Table 3 Overall outcome of treatment according to demographic origin and risk factors of non-Israeli citizens in Israel; 2000–2014
Variable | Treatment Success | Total | OR | 95% CI | ||
|---|---|---|---|---|---|---|
No n(%) | Yes n(%) | |||||
Sex | Male | 138 (13.2) | 905 (86.8) | 1043 | 0.491 | [0.315–0.764] |
Female | 64 (12.5) | 449 (87.5) | 513 | – | – | |
Overall | 202 (13.0%) | 1354 (87.0%) | 1556 | |||
Region | Horn of Africa | 63 (7.2) | 812 (92.8) | 875 | 4.006 | [1.810–8.870] |
Asia | 64 (16.1) | 333 (83.9) | 397 | 1.096 | [0.492–2.439] | |
Sub-Saharan | 15 (24.6) | 46 (75.4) | 61 | 0.880 | [0.333–2.325] | |
Eastern Europe | 40 (35.4) | 73 (64.6) | 113 | 0.556 | [0.236–1.311] | |
Other | 20 (18.2) | 90 (81.8) | 110 | – | – | |
Length of Stay | < 2 yrs | 98 (11.7) | 743 (88.3) | 841 | 0.829 | [0.542–1.269] |
> 2 yrs | 42 (11.9) | 312 (88.1) | 354 | – | – | |
HIV Status | Negative | 179 (12.1) | 1296 (87.9) | 1475 | 3.025 | [1.582–5.786] |
Positive | 22 (28.2) | 56 (71.8) | 78 | – | – | |